Immuno-Oncology 360° Summit

Events

Immuno-Oncology 360° is a comprehensive program providing exposure to the entire spectrum of R&D, addressing key aspects from all facets of IO including:

Discovery / Preclinical Science
Translational Science
Clinical Development
Business Aspects

Investor Relations
Emerging Technologies
Biomarkers / Diagnostics
Trends in the Field

Dr Axel Hoos, GSK and Dr James Gulley, NCI, together led the design of the 4th annual Immuno-Oncology 360° program to include 45 speakers and over 30 talks. We are delighted to announce that Dr Andrew Baum is confirmed as the investor relations plenary keynote.